Sylvia McBrinn insider trades: BioAtla (BCAB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sylvia reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | BCAB | ↑ Buy | 4,000 | $2.33 | $9K | Direct | Dec 26, 2023 (0d) |
| Sep 8, 2023 | BCAB | ↑ Buy | 2,000 | $2.54 | $5K | Direct | Sep 13, 2023 (5d) |
| Mar 28, 2023 | BCAB | ↑ Buy | 4,000 | $2.35 | $9K | Direct | Jan 19, 2024 (297d) |
| Dec 19, 2022 | BCAB | ↑ Buy | 3,700 | $8.33 | $31K | Direct | Dec 19, 2022 (0d) |
| Nov 22, 2022 | BCAB | ↑ Buy | 2,000 | $8.27 | $17K | Direct | Nov 23, 2022 (1d) |
| Sep 13, 2022 | BCAB | ↑ Buy | 3,000 | $8.63 | $26K | Direct | Sep 15, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sylvia McBrinn's insider trades
Sylvia McBrinn is an insider at BioAtla (BCAB). Since Sep 13, 2022, Sylvia has reported 6 open-market purchases worth $97K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.